Danimer Scientific — Q2 2022 Earnings Presentation
13 slides from Danimer Scientific's earnings presentation, Aug 9, 2022
Slide 1: Second Quarter 2022 Earnings Presentation
Second Quarter 2022 Earnings Presentation August 9, 2022
Slide 2: Disclaimer
Disclaimer This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitatio
Slide 3: Danimer's Strategic Priorities
Danimer’s Strategic Priorities Expand Capacity to Achieve Scale 1 2 3 4 5 6 Lead with Innovation to Address a Broad Range of Customer Needs Grow Customer Partnerships and Product Volume Commitments Secure Cost-Effective Inputs Attain Favorable Unit Economics to Enhance Margins Enhance Team Capabilit
Slide 4: Recent Business Highlights
Recent Business Highlights Business Highlights Continued execution of growth strategy to transform the bioplastics market PHA revenues up ~85% YoY, now representing 61% of total revenues Expanded partnership with Kemira to commercialize biodegradable aqueous coatings Plackers announced compostable d
Slide 5: Customer Partnerships & Business Development Initiatives
Customer Partnerships & Business Development Initiatives Exclusive license and supply agreement to commercialize PHA based aqueous coatings to be used on paper-based food & beverage applications Expected to be immediately cash flow positive upon launch with no significant capex Business Development
Slide 6: Expand Capacity: Kentucky Facility Update
Expand Capacity: Kentucky Facility Update – Phase II Started Commissioning in June Kentucky Facility Expansion Update: Facility capacity expanded to ~65mm lbs. of Nodax-based finished product, annually(1) Phase I (Completed 2020): ~20mm lbs. annually(1) Phase II (Started Commissioning in Q2 2022): ~
Slide 7: Expand Capacity: Bainbridge Greenfield Facility Update
Expand Capacity: Bainbridge Greenfield Facility Update Facility Build Out Timeline Greenfield Facility Overview Commentary Location of Greenfield site selected in Georgia due to better utilities rates and incentives Some equipment has been pre-ordered to avoid higher prices, but inflation remains a
Slide 8: Q2 2022 Financial Summary
Q2 2022 Financial Summary PHA-based revenues increased by ~85% YoY, representing 61% of revenue vs 29% in Q2 2021 Gross profit down YoY due lower R&D gross profit and shift in product mix Prior increases in headcount in R&D and SG&A YoY to support expansion plans Key Messages Financial Summary Note:
Slide 9: Financial Outlook
Financial Outlook 4% PHA PHA Gross Margin Total Gross Margin SG&A & R&D as % of Sales Danimer Catalytic Technologies Profit Contribution Adjusted EBITDA 2022E Adj. EBITDA of ($45) - ($35) Million Expect 2022E Capex of $175 to $185 million(1) and year end cash balance in excess of $60 million Change
Slide 10: Forward Catalysts
Forward Catalysts Continued focus on driving operational costs down as we scale production Large and growing TAM Believed to be the only PHA product offering at commercial scale production Increasing governmental regulations on single-plastic uses Demand from blue chip multinational customers Buildi
Slide 11: Appendix
4 danimer ~ scientific Appendix Per nin yy -
Slide 12: EBITDA and EBITDAR Reconciliation
EBITDA and EBITDAR Reconciliation Note: Totals may not foot due to rounding.
Slide 13: Adjusted Gross Profit Reconciliation
Adjusted Gross Profit Reconciliation Note: Totals may not foot due to rounding.